gadolinium dtpa has been researched along with a-83-01 in 2 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (a-83-01) | Trials (a-83-01) | Recent Studies (post-2010) (a-83-01) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 48 | 0 | 42 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, Y; Kawano, K; Kuribayashi, H; Maitani, Y; Minowa, T; Shiraishi, K; Sugino, T; Yokoyama, M | 1 |
| Kawano, K; Maitani, Y | 1 |
1 review(s) available for gadolinium dtpa and a-83-01
| Article | Year |
|---|---|
[Tumor permeability of nanocarriers observed by dynamic contrast-enhanced magnetic resonance imaging].
Topics: Animals; Capillary Permeability; Contrast Media; Doxorubicin; Gadolinium DTPA; Humans; Liposomes; Magnetic Resonance Imaging; Mice; Neoplasms; Pyrazoles; Stimulation, Chemical; Thiocarbamates; Thiosemicarbazones; Transforming Growth Factor beta | 2010 |
1 other study(ies) available for gadolinium dtpa and a-83-01
| Article | Year |
|---|---|
Increase in tumour permeability following TGF-beta type I receptor-inhibitor treatment observed by dynamic contrast-enhanced MRI.
Topics: Animals; Capillary Permeability; Cell Growth Processes; Cell Line, Tumor; Contrast Media; Diffusion Magnetic Resonance Imaging; Endothelial Cells; Female; Gadolinium DTPA; Humans; Mice; Neoplasms, Experimental; Neovascularization, Pathologic; Protein Serine-Threonine Kinases; Pyrazoles; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Thiocarbamates; Thiosemicarbazones | 2009 |